Search
Search Results
##search.searchResults.foundPlural##
-
-
How I treat acute and persistent sickle cell pain
1936PDF: 1119HTML: 485 -
A SEROPREVALENCE OF HBV, HCV AND HIV-1 AND CORRELATION WITH MOLECULAR MARKERS AMONG MULTI-TRANSFUSED THALASSEMIA PATIENTS IN WESTERN INDIA Incidence of serology & molecular of HIV, HBV and HCV in thalassemia patients
1347PDF: 765HTML: 512 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2019PDF: 760HTML: 3113 -
ACUTE LUNG INJURY COMPLICATING BLOOD TRANSFUSION IN POST-PARTUM HEMORRHAGE: INCIDENCE AND RISK FACTORS.
2450PDF: 1231HTML: 3602Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors.: 410 -
BACK TO THE “GOLD STANDARD”: HOW PRECISE IS HEMATOCRIT DETECTION TODAY? Novel ImageJ-based approach for the precise hematocrit measurement
2074PDF: 830HTML: 481 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4513PDF: 1926HTML: 17795 -
MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman
3254PDF: 1613HTML: 432 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9087PDF: 6064HTML: 87964Fig.1b: 186Fig.1c: 190Fig.2a: 178Fig.2b: 177Fig.4: 189Fig.2c: 187Fig.3: 185Tab.1: 228Tab.2: 207Tab.3: 190Tab.4: 224Fig1a: 187 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2589PDF: 801HTML: 5216 -
APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE
2564PDF: 967HTML: 15111 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1382HTML: 446PDF: 824 -
PERPHERAL BLOOD CELL MITOCHONDRIAL DYSFUNCTION IN MYELODYSPLASTIC SYNDROMECAN BE IMPROVED BY A COMBINATION OF COENZYME Q10 AND CARNITINE Blood cell mitochondrial dysfunction in myelodysplastic syndrome
1104PDF: 765HTML: 295 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7979PDF: 4152HTML: 7471 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
3999PDF: 1055HTML: 3595Untitled: 177Cneo. Fig.1: 114Untitled: 105Untitled: 127Untitled: 133 -
NURSING MANAGEMENT OF HAEMORRHAGIC CYSTITIS IN PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE ITALIAN SURVEY Nursing management of haemorrhagic cystitis
1863PDF: 1053HTML: 281 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2784PDF: 1830HTML: 3668Pellagatti Fig 1: 214Pellagatti Fig. 2: 212 -
GROUP-BASED TRAJECTORY MODELING OF PLATELET IN PATIENTS WITH APLASTIC ANEMIA: A STUDY BASED ON THE MIMIC DATABASE
1008PDF: 997Suppl. Files: 637HTML: 139 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2188PDF: 1201HTML: 3747 -
-
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2808PDF: 1010HTML: 5522 -
THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES Gene therapy for Hemoglobinopathies.
2152PDF: 1287Html: 284 -
POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.
770PDF: 440Suppl. Files: 120HTML: 112 -
STUDY OF SERUM HAPTOGLOBIN LEVEL AND ITS RELATION TO ERYTHROPOIETIC ACTIVITY IN BETA THALASSEMIA CHILDREN .
2191PDF: 1169HTML: 2588Study of serum haptoglobin level in thalassemia: 347Figures: 177 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4822PDF: 1809HTML: 2160 -
Measurement of erythrocyte lifespan using a CO breath test in patients with thalassemia and the impact of treatment erythrocyte lifespan in patients with thalassemia
755PDF: 546HTML: 161 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
2920PDF: 1592HTML: 234







